| 1 | Are 90% of deaths from cancer caused by metastases? | Cancer Medicine | 2019 | 692 |
| 2 | Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science | Cancer Medicine | 2019 | 565 |
| 3 | β‐caryophyllene and β‐caryophyllene oxide—natural compounds of anticancer and analgesic properties | Cancer Medicine | 2016 | 550 |
| 4 | Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy | Cancer Medicine | 2018 | 522 |
| 5 | Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis | Cancer Medicine | 2017 | 503 |
| 6 | Nrf2 in cancers: A double‐edged sword | Cancer Medicine | 2019 | 370 |
| 7 | Microsatellite instability status determined by next‐generation sequencing and compared with PD‐L1 and tumor mutational burden in 11,348 patients | Cancer Medicine | 2018 | 348 |
| 8 | Role of tumor microenvironment in cancer progression and therapeutic strategy | Cancer Medicine | 2023 | 324 |
| 9 | New prognostic factors and scoring system for patients with skeletal metastasis | Cancer Medicine | 2014 | 322 |
| 10 | Ovarian cancer: Current status and strategies for improving therapeutic outcomes | Cancer Medicine | 2019 | 312 |
| 11 | Iron overloaded polarizes macrophage to proinflammation phenotype through ROS/acetyl‐p53 pathway | Cancer Medicine | 2018 | 286 |
| 12 | PD‐1 as a potential target in cancer therapy | Cancer Medicine | 2013 | 283 |
| 13 | Using adaptive magnetic resonance image‐guided radiation therapy for treatment of inoperable pancreatic cancer | Cancer Medicine | 2019 | 278 |
| 14 | Interferon gamma in cancer immunotherapy | Cancer Medicine | 2018 | 269 |
| 15 | Crosstalk between cancer and immune cells: Role of tumor‐associated macrophages in the tumor microenvironment | Cancer Medicine | 2019 | 260 |
| 16 | The precision prevention and therapy of HPV‐related cervical cancer: new concepts and clinical implications | Cancer Medicine | 2018 | 244 |
| 17 | Sarcopenia and adverse health‐related outcomes: An umbrella review of meta‐analyses of observational studies | Cancer Medicine | 2020 | 244 |
| 18 | Metastatic patterns and survival outcomes in patients with stage IV colon cancer: A population‐based analysis | Cancer Medicine | 2020 | 231 |
| 19 | Ipilimumab and radiation therapy for melanoma brain metastases | Cancer Medicine | 2013 | 213 |
| 20 | Nisin, an apoptogenic bacteriocin and food preservative, attenuates
HNSCC
tumorigenesis via
CHAC
1 | Cancer Medicine | 2012 | 208 |
| 21 | Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities | Cancer Medicine | 2019 | 208 |
| 22 | Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K‐Akt signaling in gastric cancer | Cancer Medicine | 2019 | 207 |
| 23 | Adherence to Mediterranean diet and risk of cancer: an updated systematic review and meta‐analysis of observational studies | Cancer Medicine | 2015 | 205 |
| 24 | Vessel co‐option in primary human tumors and metastases: an obstacle to effective anti‐angiogenic treatment? | Cancer Medicine | 2013 | 197 |
| 25 | Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models | Cancer Medicine | 2018 | 196 |
| 26 | Cancer survival disparities by health insurance status | Cancer Medicine | 2013 | 195 |
| 27 | Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma | Cancer Medicine | 2016 | 192 |
| 28 | Depression and prostate cancer risk: A Mendelian randomization study | Cancer Medicine | 2020 | 192 |
| 29 | RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin–RGD interactions | Cancer Medicine | 2024 | 192 |
| 30 | BAY 87‐2243, a highly potent and selective inhibitor of hypoxia‐induced gene activation has antitumor activities by inhibition of mitochondrial complex I | Cancer Medicine | 2013 | 189 |
| 31 | Global circular RNA expression profile of human gastric cancer and its clinical significance | Cancer Medicine | 2017 | 189 |
| 32 | Cancer‐associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma | Cancer Medicine | 2017 | 172 |
| 33 | Overexpression of Snail induces epithelial–mesenchymal transition and a cancer stem cell–like phenotype in human colorectal cancer cells | Cancer Medicine | 2012 | 168 |
| 34 | A novel plasma circular RNA circFARSA is a potential biomarker for non‐small cell lung cancer | Cancer Medicine | 2018 | 164 |
| 35 | Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blocker | Cancer Medicine | 2020 | 164 |
| 36 | LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR‐184 expression | Cancer Medicine | 2017 | 162 |
| 37 | Anti‐PD‐1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases | Cancer Medicine | 2018 | 156 |
| 38 | MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics | Cancer Medicine | 2016 | 152 |
| 39 | Quercetin shows anti‐tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2/STAT3 signaling pathway | Cancer Medicine | 2019 | 152 |
| 40 | The role of laser interstitial thermal therapy in enhancing progression‐free survival of difficult‐to‐access high‐grade gliomas: a multicenter study | Cancer Medicine | 2014 | 147 |
| 41 | Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer | Cancer Medicine | 2018 | 146 |
| 42 | Automated home monitoring and management of patient‐reported symptoms during chemotherapy: results of the symptom care at home RCT | Cancer Medicine | 2017 | 143 |
| 43 | Profiles of immune infiltration in colorectal cancer and their clinical significant: A gene expression‐based study | Cancer Medicine | 2018 | 142 |
| 44 | Changing trends in the disease burden of esophageal cancer in China from 1990 to 2017 and its predicted level in 25 years | Cancer Medicine | 2021 | 142 |
| 45 | Symptom clusters experienced by breast cancer patients at various treatment stages: A systematic review | Cancer Medicine | 2021 | 141 |
| 46 | U‐251 revisited: genetic drift and phenotypic consequences of long‐term cultures of glioblastoma cells | Cancer Medicine | 2014 | 139 |
| 47 | Integrating natural compounds and nanoparticle‐based drug delivery systems: A novel strategy for enhanced efficacy and selectivity in cancer therapy | Cancer Medicine | 2024 | 137 |
| 48 | Gene panel testing of 5589 BRCA1/2‐negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer | Cancer Medicine | 2018 | 135 |
| 49 | Lean body mass as an independent determinant of dose‐limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens | Cancer Medicine | 2016 | 134 |
| 50 | HuR‐regulated lncRNA NEAT1 stability in tumorigenesis and progression of ovarian cancer | Cancer Medicine | 2016 | 133 |